SIMRIS B logo

Simris Group AB (PUBL) Stock Price

OM:SIMRIS B Community·SEK 135.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SIMRIS B Share Price Performance

SEK 0.10
0.03 (43.16%)
SEK 0.10
0.03 (43.16%)
Price SEK 0.10

SIMRIS B Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with imperfect balance sheet.

6 Risks
0 Rewards

Simris Group AB (PUBL) Key Details

SEK 2.6m

Revenue

-SEK 29.0k

Cost of Revenue

SEK 2.7m

Gross Profit

SEK 29.7m

Other Expenses

-SEK 27.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 12, 2026
-0.02
101.10%
-1,020.52%
0%
View Full Analysis

About SIMRIS B

Founded
2011
Employees
5
CEO
Daniel Kubitza
WebsiteView website
www.simrisgroup.com

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.

Recent SIMRIS B News & Updates

Recent updates

No updates